Increased population of CD4+CD25high regulatory T cells with their higher apoptotic and proliferating status in peripheral blood of acute myeloid leukemia patients

European Journal of Haematology

Volumn 75, Issue 6, 2005, Pages 468-476

  Wang, Xingbing ^a   Zheng, Jine ^a   Liu, Jun ^a   Yao, Junxia ^a   He, Yanli ^a   Li, Xiaoqing ^a   Yu, Jingming ^a   Yang, Jing ^a   Liu, Zhongping ^a   Huang, Shiang ^a,b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Acute myeloid leukemia; Apoptosis; CD4+CD25+ regulatory T cells; Cytokine; Immunosuppression; Proliferation

Indexed keywords

CD4 ANTIGEN; CD45 ANTIGEN; CD69 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; INTERLEUKIN 5; KI 67 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ANTIGEN PRESENTING CELL; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREGULATION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PERIPHERAL CIRCULATION; PHENOTYPE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; APOPTOSIS; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOKINES; FEMALE; HUMANS; KI-67 ANTIGEN; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-2;

EID: 28044434385     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2005.00537.x     Document Type: Article

References (34)

1. HIRANO N, TAKAHASHI T, OHTAKE S, et al. Expression of costimulatory molecules in human leukemias. Leukemia 1996;10:1168-1176.
2. NOTTER M, WILLINGER T, ERBEN U, et al. Targeting of a B7-1 (CD80) immunoglobulin G fusion protein to acute myeloid leukemia blasts increases their costimulatory activity for autologous remission T cells. Blood 2001;97:3138-3145.
3. BUZYN A, PETIT F, OSTANKOVITCH M, FIGUEIREDO S, et al. Membrane-bound Fas (Apo-1/CD95) ligand on leukemic cells: a mechanism of tumor immune escape in leukemia patients. Blood 1999;94:3135-3140.
4. BUGGINS AG, LEA N, GAKEN J, et al. Effect of costimulation and the microenvironment on antigen presentation by leukemic cells. Blood 1999;94:3479-3490.
5. BUGGINS AG, MILOJKOVIC D, ARNO MJ, et al. Microenvironment produced by acute myeloid leukemia cells prevents T cell activation and proliferation by inhibition of NF-kappaB, c-Myc, and pRb pathways. J Immunol 2001;167:6021-6030.
6. CHEN X, WOICIECHOWSKY A, RAFFEGERST S, et al. Impaired expression of the CD3-zeta chain in peripheral blood T cells of patients with chronic myeloid leukaemia results in an increased susceptibility to apoptosis. Br J Haematol 2000;111:817-825.
7. COHEN JL, TRENADO A, VASEY D, et al. CD4(+)CD25(+) immunoregulatory T cells: new therapeutics for graft-versus-host disease. J Exp Med 2002;196:401-406.
8. WOOD KJ, SAKAGUCHI S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003;3:199-210.
9. CRISPIN JC, VARGAS MI, ALCOCER-VARELA J. Immunoregulatory T cells in autoimmunity. Autoimmun Rev 2004;3:45-51.
10. + regulatory T cells. Semin Immunol 2004;16:89-98.
11. high regulatory cells in human peripheral blood. J Immunol 2001;167:1245-1253.
12. DIECKMANN D, PLOTTNER H, BERCHTOLD S, et al. Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood. J Exp Med 2001;193:1303-1310.
13. JONULEIT H, SCHMITT E, STASSEN M, et al. Identification and functional characterization of human CD4(+) CD25(+) T cells with regulatory properties isolated from peripheral blood. J Exp Med 2001;193:1285-1294.
14. LEVINGS MK, SANGREGORIO R, RONCAROLO MG. Human CD25(+)CD4(+) T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J Exp Med 2001;193:1295-1302.
15. + regulatory T cells. Eur J Immunol 2002;32:1621-1630.
16. NG WF, DUGGAN PJ, PONCHEL F, MATARESE G, LOMBARDI G, EDWARDS AD, ISAACS JD, LECHLER RI. Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells. Blood 2001;98:2736-2744.
17. + T cells: a common basis between tumor immunity and autoimmunity. J Immunol 1999;163:5211-5219.
18. + regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses. J Exp Med 2001;194:823-830.
19. + regulatory cells augments the generation of specific immune T cells in tumor-draining lymph nodes. J Immunother 2002;25:207-217.
20. + T cells in tumors from patients with early stage non-small cell lung cancer and late-stage ovarian cancer. Cancer Res 2001;61:4766-4775.
21. ICHIHARA F, KONO K, TAKAHASHI A, et al. Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers. Clin Cancer Res 2003;9:4404-4408.
22. WOLF AM, WOLF D, STEURER M, et al. Increase of regulatory T cells in the peripheral blood of cancer patients. Clin Cancer Res 2003;9:606-612.
23. LIYANAGE UK, MOORE TT, JOO H-G, et al. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J Immunol 2002;169:2756-2761.
24. WOO EY, YEH H, CHU CS, et al. Regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation. J Immunol 2002;168:4272-4276.
25. MARSHALL NA, CHRISTIE LE, MUNRO LR, et al. Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma. Blood 2004;103:1755-1762.
26. + regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression. Cancer 2003;98:1089-1099.
27. DIECKMANN D, BRUETT CH, PLOETTNER H, et al. Human CD4(+)CD25(+) regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells. J Exp Med 2002;196:247-253.
28. MOCELLIN S, WANG E, MARINCOLA FM. Cytokines and immune response in the tumor microenvironment. J Immunother 2001;24:392-407.
29. MAHNKE K, QIAN Y, KNOP J, ENK AH. Induction of CD4+/CD25+ regulatory T cells by targeting of antigens to immature dendritic cells. Blood 2003;101:4862-4869.
30. + regulatory T cells by antigen-processing dendritic cells. J Exp Med 2003;198:235-247.
31. + T cell response to repetitive stimulation with antigen-presenting cells in vitro: implications in designing antigen-presenting cell-based tumor vaccines. J Immunol 1999;162:5576-5583.
32. KUSMARTSEV S, GABRILOVICH DI. Immature myeloid cells and cancer-associated immune suppression. Cancer Immunol Immunother 2002;51:293-298.
33. MOHTY M, JARROSSAY D, LAFAGE-POCHITALOFF M, et al. Circulating blood dendritic cells from myeloid leukemia patients display quantitative and cytogenetic abnormalities as well as functional impairment. Blood 2001;98:3750-3756.
34. - precursors. J Immunol 2002;169:4183-4189.